Collegium Pharmaceutical
COLL
eBay
EBAY
Halozyme Therapeutics
HALO
SilverCrest Metals
SILV
Workday
WDAY
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | 41.76%13.05K | -98.42%4.53K | -98.67%5.31K | -98.68%5.31K | -98.68%5.31K | -98.08%9.21K | 7,872.88%287.18K | 8,558.91%398.48K | 8,657.32%403.01K | --403.01K |
-Cash and cash equivalents | 41.76%13.05K | -98.42%4.53K | -98.67%5.31K | -98.68%5.31K | -98.68%5.31K | -98.08%9.21K | 7,872.88%287.18K | 8,558.91%398.48K | 8,657.32%403.01K | --403.01K |
Receivables | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | --521 | --521 |
-Other receivables | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --521 | --521 |
Prepaid assets | 15.70%20.25K | 192.27%102.3K | ---- | ---- | ---- | --17.5K | --35K | ---- | ---- | ---- |
Total current assets | 24.68%33.3K | -66.84%106.83K | -98.67%5.31K | -98.68%5.31K | -98.68%5.31K | -94.43%26.71K | 77.76%322.19K | 128.84%398.48K | 138.71%403.53K | --403.53K |
Non current assets | ||||||||||
Other non current assets | -59.75%25.78M | -25.90%58.02M | -25.98%57.27M | -26.54%56.23M | -26.54%56.23M | -15.60%64.06M | --78.3M | --77.36M | --76.54M | --76.54M |
Total non current assets | -59.75%25.78M | -25.90%58.02M | -25.98%57.27M | -26.54%56.23M | -26.54%56.23M | -15.60%64.06M | --78.3M | --77.36M | --76.54M | --76.54M |
Total assets | -59.72%25.82M | -26.07%58.13M | -26.35%57.27M | -26.91%56.24M | -26.91%56.24M | -16.09%64.09M | 43,280.99%78.63M | 44,557.59%77.76M | 45,416.11%76.94M | --76.94M |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | --744.06K | --144.06K | --62.26K | --54.54K | --54.54K | ---- | ---- | ---- | ---- | ---- |
-Due to related parties current | --144.06K | --144.06K | --62.26K | --54.54K | --54.54K | ---- | ---- | ---- | --0 | --0 |
-Other payable | --600K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Current accrued expenses | --1.17M | --1.07M | --1.05M | 585.93%1.08M | 585.93%1.08M | ---- | ---- | ---- | --157.05K | --157.05K |
Current debt and capital lease obligation | 8,946.25%904.63K | --851.11K | --770.11K | --400.11K | --400.11K | --10K | ---- | ---- | ---- | ---- |
-Current debt | 8,946.25%904.63K | --851.11K | --770.11K | --400.11K | --400.11K | --10K | ---- | ---- | ---- | ---- |
Current liabilities | 203.49%2.82M | 534.67%2.06M | 571.40%1.88M | 875.42%1.53M | 875.42%1.53M | 2,701.42%928.2K | 103.64%324.76K | 83.95%280.26K | 6.63%157.05K | --157.05K |
Non current liabilities | ||||||||||
Total non current liabilities | 14.63%2.97M | 14.63%2.97M | 14.63%2.97M | 0.00%2.59M | 0.00%2.59M | 0.00%2.59M | --2.59M | --2.59M | --2.59M | --2.59M |
Total liabilities | 64.49%5.78M | 72.62%5.03M | 69.04%4.85M | 50.09%4.12M | 50.09%4.12M | 34.15%3.52M | 1,726.12%2.91M | 1,782.23%2.87M | 1,763.49%2.74M | --2.74M |
Shareholders'equity | ||||||||||
Share capital | -59.75%25.78M | -25.90%58.02M | -25.98%57.27M | -26.54%56.23M | -26.54%56.23M | -15.60%64.06M | 41,874,347.06%78.31M | 41,371,022.99%77.36M | 41,373,782.70%76.54M | --76.54M |
-common stock | -59.75%25.78M | -25.90%58.02M | -25.98%57.27M | -26.54%56.23M | -26.54%56.23M | -15.60%64.06M | 41,874,347.06%78.31M | 41,371,022.99%77.36M | 41,373,782.70%76.54M | --76.54M |
Retained earnings | -64.79%-5.75M | -89.96%-4.92M | -96.10%-4.84M | -75.73%-4.11M | -75.73%-4.11M | -62.94%-3.49M | -80,095.23%-2.59M | -76,355.42%-2.47M | -72,384.43%-2.34M | ---2.34M |
Paid-in capital | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Total stockholders'equity | -66.93%20.03M | -29.87%53.1M | -30.00%52.42M | -29.76%52.12M | -29.76%52.12M | -17.88%60.57M | 347,694.72%75.71M | 343,926.14%74.89M | 340,738.02%74.2M | --74.2M |
Total equity | -66.93%20.03M | -29.87%53.1M | -30.00%52.42M | -29.76%52.12M | -29.76%52.12M | -17.88%60.57M | 347,694.72%75.71M | 343,926.14%74.89M | 340,738.02%74.2M | --74.2M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |